Skip to main content

Table 1 Breakdown of different costs per diagnosed type 2 diabetes patient in the Singapore male working-age population by age group from 2010 to 2050 (in USD)

From: Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050

Year Age group Diabetes population Indirect productivity loss Total economic costa
Absenteeism Presenteeism Diabetes-related non-participation Lost capacity from premature mortality Total indirect cost
2010 20–29 2,396 150 1,614 - - 1,764 3,260
30–39 8,205 260 2,795 - 1,874 4,929 6,425
40–49 19,334 229 2,464 - 3,428 6,121 7,617
50–59 27,760 144 1,555 1,270 4,109 7,078 8,574
60–69 21,114 67 722 240 2,340 3,369 4,865
2030 20–29 2,920 225 2,426 - 394 3,046 4,542
30–39 10,149 386 4,154 - 1,974 6,513 8,009
40–49 22,004 340 3,663 - 3,821 7,824 9,320
50–59 35,009 213 2,296 1,882 5,256 9,648 11,144
60–69 50,298 95 1,022 229 2,461 3,806 5,302
2050 20–29 3,238 340 3,657 - - 3,996 5,492
30–39 12,013 573 6,172 - 2,520 9,265 10,761
40–49 25,323 505 5,442 - 4,512 10,459 11,955
50–59 42,216 318 3,422 2,748 5,186 11,674 13,170
60–69 58,576 142 1,534 394 2,326 4,397 5,893
  1. aTotal economic cost = Total indirect cost + Excess direct medical cost of US$1,496.03